ghk-cu bdnf GHK-CU — Research Peptide, Third-Party

According to Professor Adrian R Martineau, 1 March 2015, in his article discussing the main recommendations for healthcare practitioners in NICE Public Health (PH) guidance 56 on Vitamin D: increasing supplement use among at-risk groups: "Health professionals do not need to routinely test vitamin D status in asymptomatic people in at-risk groups before advising them to take a vitamin D supplement

PMID 41459016

The longest published trial data covers up to 84 weeks

Not just a shopping list

Guo P, Liu L, Yang X, Li M, Zhao Q, Wu H

SMAR1-derived P44 peptide retains its tumor suppressor function through modulation of p53